Capital Group Investment Management Pte. Ltd. Alnylam Pharmaceuticals, Inc. Transaction History

Capital Group Investment Management Pte. Ltd.

$566 Million
Q3 2025

A detailed history of Capital Group Investment Management Pte. Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital Group Investment Management Pte. Ltd. holds 16,863 shares of ALNY stock, worth $7.57 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares

16,863

Previous 17,738 4.93%

Holding current value

$7.57 Million

Previous $5.78 Million 32.94%

% of portfolio

1.36%

Previous 1.08%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$311.12 - $482.13 $272,230 - $421,863	-875 Reduced 4.93%	16,863 $7.69 Million
Q2 2025 Aug 13, 2025	BUY	$224.32 - $326.09 $87,036 - $126,522	388 Added 2.24%	17,738 $5.78 Million
Q1 2025 May 12, 2025	BUY	$233.07 - $290.7 $41,719 - $52,035	179 Added 1.04%	17,350 $4.68 Million
Q4 2024 Feb 13, 2025	SELL	$232.27 - $300.43 $969,959 - $1.25 Million	-4,176 Reduced 19.56%	17,171 $4.04 Million
Q3 2024 Nov 13, 2024	BUY	$233.81 - $287.01 $415,480 - $510,016	1,777 Added 9.08%	21,347 $5.87 Million

Q2 2024 Aug 13, 2024	BUY	$143.31 - $247.0 $486,824 - $839,059	3,397 Added 21.0%	19,570 $4.76 Million
Q1 2024 May 14, 2024	SELL	$146.51 - $198.2 $2.38 Million - $3.22 Million	-16,251 Reduced 50.12%	16,173 $2.42 Million
Q4 2023 Feb 13, 2024	SELL	$151.41 - $196.57 $3.19 Million - $4.15 Million	-21,092 Reduced 39.41%	32,424 $6.21 Million
Q3 2023 Nov 13, 2023	BUY	$170.77 - $211.65 $5.81 Million - $7.21 Million	34,048 Added 174.89%	53,516 $9.48 Million
Q1 2023 May 15, 2023	SELL	$182.66 - $235.53 $471,628 - $608,138	-2,582 Reduced 11.71%	19,468 $3.9 Million
Q4 2022 Feb 14, 2023	BUY	$185.53 - $241.31 $4.09 Million - $5.32 Million	22,050 New	22,050 $0

Others Institutions Holding ALNY

# of Institutions

917

Shares Held

117M

Call Options Held

1.25M

Put Options Held

1.49M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $55.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Investment Management Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Investment Management Pte. Ltd. with notifications on news.

Account

Capital Group Investment Management Pte. Ltd. Alnylam Pharmaceuticals, Inc. Transaction History